Bond ra

Citeras av

	Alla	Sedan 2019
Citat	9731	1635
h-index	44	21
i10-index	75	38

540

270

135

405

198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202427 35 37 33 61 60 62 137 250 273 323 360 336 336 258 282 289 297 262 290 334 271 307 374 288 364 338 285 449 527 445 350 330 317 301 270 64

Offentlig åtkomst

Visa alla

28 artiklar

2 artiklar

tillgänglig

inte tillgänglig

Enligt krav från finansiärer

Medförfattare

Robert J. LefkowitzJames B. Duke Professor of Medicine, Biochemistry, Chemistry; HHMI, Duke UniversityVerifierad e-postadress på receptor-biol.duke.edu
Sergio ParraPrincipal Clinical Scientist II, Vapogenix, Inc.Verifierad e-postadress på vapogenix.com
Burton DickeyProfessor of Pulmonary Medicine, MD Anderson Cancer CenterVerifierad e-postadress på mdanderson.org
Howard RockmanDuke UniversityVerifierad e-postadress på duke.edu
Paul M VanhoutteChair Professor in Pharmacology, University of Hong KongVerifierad e-postadress på hku.hk
Nicola A. Hanania, MD, MSProfessor, Baylor College of MedicineVerifierad e-postadress på bcm.edu
Nour Al-SawalhaDepartment of Clinical Pharmacy, College of Pharmacy, Jordan University of Science and TechnologyVerifierad e-postadress på just.edu.jo
Vaidehi ThanawalaVir BiotechnologyVerifierad e-postadress på vir.bio
Walter J KochDuke UniversityVerifierad e-postadress på Duke.edu
Zsuzsanna Callaerts-VeghKULeuvenVerifierad e-postadress på kuleuven.be
John Christie (Ian) McGrathEmeritus Professor of Physiology, Glasgow & Sydney UniversitiesVerifierad e-postadress på sydney.edu.au
Richard J. Simpson, PhD FACSMProfessor, The University of ArizonaVerifierad e-postadress på email.arizona.edu
Steve AlexanderUniversity of NottinghamVerifierad e-postadress på nottingham.ac.uk
Michael J. CurtisKing's College LondonVerifierad e-postadress på kcl.ac.uk
Graeme MilliganUniversity of GlasgowVerifierad e-postadress på glasgow.ac.uk
Angelo A. IzzoUniversity of naples Federico II, pharmacognosy, pharmacologyVerifierad e-postadress på unina.it
Andrew J LawrenceFlorey Institute of Neuroscience & Mental HealthVerifierad e-postadress på florey.edu.au
daniel hoyerU of MelbourneVerifierad e-postadress på unimelb.edu.au
Yuansheng GaoProfessor of Pathophysiology,Peking University,ChinaVerifierad e-postadress på bjmu.edu.cn
Michel BouvierProfessor of Biochem. and Mol. Med., IRIC, Univ. de MontréalVerifierad e-postadress på umontreal.ca

Följ

Bond ra

University of Houston

Verifierad e-postadress på uh.edu


Titel Sortera efter citat Sortera efter år Sortera efter titel	Citeras av Citeras av	År
Experimental design and analysis and their reporting: new guidance for publication in BJP MJ Curtis, RA Bond, D Spina, A Ahluwalia, SPA Alexander, MA Giembycz, ... British journal of pharmacology 172 (14), 3461, 2015	1118	2015
Enhanced Myocardial Function in Transgenic Mice Overexpressing the β₂-Adrenergic Receptor CA Milano, LF Allen, HA Rockman, PC Dolber, TR McMinn, KR Chien, ... Science 264 (5158), 582-586, 1994	931	1994
Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a βARK inhibitor WJ Koch, HA Rockman, P Samama, RA Hamilton, RA Bond, CA Milano, ... Science 268 (5215), 1350-1353, 1995	855	1995
Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the β₂-adrenoceptor RA Bond, P Leff, TD Johnson, CA Milano, HA Rockman, TR McMinn, ... Nature 374 (6519), 272-276, 1995	554	1995
Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. CA Milano, PC Dolber, HA Rockman, RA Bond, ME Venable, LF Allen, ... Proceedings of the National Academy of Sciences 91 (21), 10109-10113, 1994	462	1994
Essential role of β-adrenergic receptor kinase 1 in cardiac development and function M Jaber, WJ Koch, H Rockman, B Smith, RA Bond, KK Sulik, J Ross Jr, ... Proceedings of the National Academy of Sciences 93 (23), 12974-12979, 1996	413	1996
Inverse agonism: pharmacological curiosity or potential therapeutic strategy? G Milligan, RA Bond, M Lee Trends in pharmacological sciences 16 (1), 10-13, 1995	360	1995
Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery RA Bond, AP IJzerman Trends in pharmacological sciences 27 (2), 92-96, 2006	296	2006
Nebivolol induces endothelium-dependent relaxations of canine coronary arteries YS Gao, T Nagao, RA Bond, WJ Janssens, PM Vanhoutte J Cardiovasc Pharmacol 17 (6), 964-9, 1991	258	1991
Effects of acute and chronic administration of β-adrenoceptor ligands on airway function in a murine model of asthma Z Callaerts-Vegh, KLJ Evans, N Dudekula, D Cuba, BJ Knoll, ... Proceedings of the National Academy of Sciences 101 (14), 4948-4953, 2004	200	2004
Inverse agonism and the regulation of receptor number G Milligan, RA Bond Trends in pharmacological sciences 18 (12), 468-474, 1997	200	1997
Subtype-specific β-adrenoceptor signaling pathways in the heart and their potential clinical implications RP Xiao, W Zhu, M Zheng, K Chakir, R Bond, EG Lakatta, H Cheng Trends in pharmacological sciences 25 (7), 358-365, 2004	194	2004
Agonist and antagonist characterization of a putative adrenoceptor with distinct pharmacological properties from the α‐and β‐subtypes RA Bond, DE Clarke British journal of pharmacology 95 (3), 723-734, 1988	194	1988
Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model LP Nguyen, O Omoluabi, S Parra, JM Frieske, C Clement, ... American journal of respiratory cell and molecular biology 38 (3), 256-262, 2008	180	2008
Definition of pharmacological receptors TP Kenakin, RA Bond, TI Bonner Pharmacological reviews 44 (3), 351-362, 1992	180	1992
Enhanced G_i Signaling Selectively Negates β₂-Adrenergic Receptor (AR)– but Not β₁-AR–Mediated Positive Inotropic Effect in Myocytes From Failing Rat Hearts RP Xiao, SJ Zhang, K Chakir, P Avdonin, W Zhu, RA Bond, CW Balke, ... Circulation 108 (13), 1633-1639, 2003	169	2003
The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study NA Hanania, S Singh, R El-Wali, M Flashner, AE Franklin, WJ Garner, ... Pulmonary pharmacology & therapeutics 21 (1), 134-141, 2008	161	2008
The IUPHAR compendium of receptor characterization and classification ML Dubocovich, DP Cardinali, P Delagrange, DN Krause, AD Strosberg, ... IUPHAR Media, London, 271-277, 2000	142	2000
The elusive nature of intrinsic efficacy WP Clarke, RA Bond Trends in pharmacological sciences 19 (7), 270-276, 1998	131	1998
β2-Adrenoceptor signaling is required for the development of an asthma phenotype in a murine model LP Nguyen, R Lin, S Parra, O Omoluabi, NA Hanania, MJ Tuvim, BJ Knoll, ... Proceedings of the National Academy of Sciences 106 (7), 2435-2440, 2009	128	2009

Systemet kan inte utföra åtgärden just nu. Försök igen senare.

Artiklar 1–20

Citat per år

Dubblettcitat

Sammanfogade citat

Lägg till medförfattareMedförfattare

Följ

Citeras av

Medförfattare